In our study, ZFP57 was downregulated in pancreatic cancer after radiotherapy and the Wnt/β-catenin pathway was activated, thereby enhancing the radioresistance of pancreatic cancer cells. Here, ZFP57 is linked to pancreatic neoplasm.